🌟 [ 40 ]   How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong [ @The Wall Street Journal ]

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests to homes with just a tube of spit. But challenges with its business model and continued data privacy concerns for consumers have brought the company once valued at $6 billion to a valuation of nearly $0, with Nasdaq threatening to delist it. WSJ explains what went wrong with Wojcicki’s biotech business. 0:00 Home DNA testing 0:49 The rise of 23andMe 2:18 The turning point 4:03 23andMe’s fall 5:23 What’s next? What Went Wrong explores the challenging conditions and decisions that led to a company s downturn. #23andMe #DNA #WSJ

:::: Visit my YouTube channel @ The Wall Street Journal ( [ 🔗 Click ‼️ ] )

🌈 🔎 How23andMeWentFrom$6BValuationtoPennyStockWSJWhatWentWrong 🌈